Search
for
Sort by
Research 271–300 of 1000+
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Emerging treatments in alopecia
- Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata
- Treatment of alopecia areata with squaric acid dibutylester
- Combination Therapy with Cyclosporine and Psoralen Plus Ultraviolet A in the Patients with Severe Alopecia Areata: A Retrospective Study with a Self-Controlled Design
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Treatment of Alopecia Areata With Topical Sensitizers
- Alopecia areata: Part 2: treatment.
- Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata
- The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future
- Chronological clinicopathological characterization of rapidly progressive alopecia areata resistant to multiple i.v. corticosteroid pulse therapies: An implication for improving the efficacy
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- Excimer lamp as an effective alternative treatment for severe alopecia areata
- What’s New in the Histologic Evaluation of Alopecia and Hair-Related Disorders?
- Bexarotene gel: A new topical therapy for alopecia areata
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Does Complement Have a Role in the Pathogenesis of Alopecia Areata?
- Alopecia in lupus: Experience from a tertiary referral centre
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- Causal effects of glutamine and lipid-related metabolites on alopecia areata: A 2-sample Mendelian randomization study
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata
- JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Coexistent frontal fibrosing alopecia with ophiasis pattern alopecia areata in a young female: A case report and review of the literature